18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
70 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

Chronic 0 7 19 26 O
HCV 8 11 27 30 B-chronic_disease
infection 12 21 31 40 I-chronic_disease
as 22 24 41 43 O
documented 25 35 44 54 O
by 36 38 55 57 O
quantifiable 39 51 58 70 O
HCV 52 55 71 74 O
RNA 56 59 75 78 O

Chronic 0 7 79 86 B-chronic_disease
Hepatitis 8 17 87 96 I-chronic_disease
B 18 19 97 98 I-chronic_disease
virus 20 25 99 104 I-chronic_disease
Infection 26 35 105 114 I-chronic_disease

Considered 0 10 115 125 O
an 11 13 126 128 O
active 14 20 129 135 O
drug 21 25 136 140 O
user 26 30 141 145 O
by 31 33 146 148 O
HCV 34 37 149 152 B-chronic_disease
provider 38 46 153 161 O
and 47 50 162 165 O
self 51 55 166 170 O
- 55 56 170 171 O
reported 56 64 171 179 O
drug 65 69 180 184 O
use 70 73 185 188 O
within 74 80 189 195 O
the 81 84 196 199 O
past 85 89 200 204 B-upper_bound
month 90 95 205 210 I-upper_bound

Decompensated 0 13 211 224 O
liver 14 19 225 230 B-chronic_disease
disease 20 27 231 238 I-chronic_disease
( 28 29 239 240 O
i.e. 29 33 240 244 O
, 33 34 244 245 O
ascites 35 42 246 253 B-chronic_disease
, 42 43 253 254 O
history 44 51 255 262 O
of 52 54 263 265 O
esophageal 55 65 266 276 B-chronic_disease
variceal 66 74 277 285 I-chronic_disease
bleeding 75 83 286 294 I-chronic_disease
, 83 84 294 295 O
hepatic 85 92 296 303 B-chronic_disease
encephalopathy 93 107 304 318 I-chronic_disease
) 107 108 318 319 O

For 0 3 320 323 O
both 4 8 324 328 O
sexes 9 14 329 334 O
, 14 15 334 335 O
an 16 18 336 338 O
unwillingness 19 32 339 352 B-contraception_consent
to 33 35 353 355 I-contraception_consent
use 36 39 356 359 I-contraception_consent
contraception 40 53 360 373 I-contraception_consent
during 54 60 374 380 O
the 61 64 381 384 O
study 65 70 385 390 O
period 71 77 391 397 O

For 0 3 398 401 O
females 4 11 402 409 B-gender
, 11 12 409 410 O
active 13 19 411 417 O
pregnancy 20 29 418 427 B-pregnancy
or 30 32 428 430 O
any 33 36 431 434 O
intent 37 43 435 441 O
to 44 46 442 444 B-pregnancy
become 47 53 445 451 I-pregnancy
pregnant 54 62 452 460 I-pregnancy

Glomerular 0 10 461 471 B-clinical_variable
filtration 11 21 472 482 I-clinical_variable
rate 22 26 483 487 I-clinical_variable
< 27 28 488 489 O
30 29 31 490 492 B-upper_bound
mL 32 34 493 495 I-upper_bound
/ 34 35 495 496 I-upper_bound
min/1.73 35 43 496 504 I-upper_bound
m2 44 46 505 507 I-upper_bound

HCV 0 3 508 511 B-chronic_disease
genotype 4 12 512 520 B-clinical_variable
1 13 14 521 522 B-lower_bound
, 14 15 522 523 O
4 16 17 524 525 O
, 17 18 525 526 O
5 19 20 527 528 O
, 20 21 528 529 O
6 22 23 530 531 B-upper_bound

HIV 0 3 532 535 B-chronic_disease
- 3 4 535 536 I-chronic_disease
infected 4 12 536 544 I-chronic_disease
men 13 16 545 548 B-gender
and 17 20 549 552 O
women 21 26 553 558 B-gender

Medications 0 11 559 570 O
not 12 15 571 574 O
recommended 16 27 575 586 O
per 28 31 587 590 O
the 32 35 591 594 O
SOF 36 39 595 598 O
/ 39 40 598 599 O
LDV 40 43 599 602 O
prescribing 44 55 603 614 O
information 56 67 615 626 O
( 68 69 627 628 O
e.g. 69 73 628 632 O
, 73 74 632 633 O
tipranavir 75 85 634 644 B-treatment
and 86 89 645 648 O
other 90 95 649 654 O
P 96 97 655 656 B-treatment
- 97 98 656 657 I-treatment
gp 98 100 657 659 I-treatment
inducers 101 109 660 668 I-treatment
, 109 110 668 669 O
tenofovir 111 120 670 679 B-treatment
disoproxil 121 131 680 690 I-treatment
fumarate 132 140 691 699 I-treatment
plus 141 145 700 704 I-treatment
cobicistat 146 156 705 715 I-treatment
, 156 157 715 716 O
rosuvastatin 158 170 717 729 B-treatment
, 170 171 729 730 O
amiodarone 172 182 731 741 B-treatment
) 182 183 741 742 O

Receipt 0 7 743 750 O
of 8 10 751 753 O
prior 11 16 754 759 B-treatment
HCV 17 20 760 763 I-treatment
treatment 21 30 764 773 I-treatment
and 31 34 774 777 O
radiographic 35 47 778 790 B-treatment
, 47 48 790 791 O
histologic 49 59 792 802 O
, 59 60 802 803 O
or 61 63 804 806 O
clinical 64 72 807 815 O
evidence 73 81 816 824 O
of 82 84 825 827 O
cirrhosis 85 94 828 837 B-chronic_disease

